148 related articles for article (PubMed ID: 18416439)
1. Sample size for equivalence trials: a case study from a vaccine lot consistency trial.
Ganju J; Izu A; Anemona A
Stat Med; 2008 Aug; 27(19):3743-54. PubMed ID: 18416439
[TBL] [Abstract][Full Text] [Related]
2. Comments on 'Sample size for equivalence trials: A case study from a vaccine lot consistency trial' by J. Ganju, A. Izu and A. Anemona, Statistics in Medicine 2008; 27:3743-3754.
Kohberger RC
Stat Med; 2009 Jan; 28(1):177-8, author reply 178-9. PubMed ID: 18937271
[No Abstract] [Full Text] [Related]
3. Comments on 'Sample size for equivalence trials: a case study from a vaccine lot consistency trial' by J. Ganju, A. Izu and A. Anemona.
Sun X; Li X; Chen J
Stat Med; 2012 Jul; 31(15):1652-3; author reply 1654. PubMed ID: 22711252
[No Abstract] [Full Text] [Related]
4. Lot consistency as an equivalence problem.
Lachenbruch PA; Rida W; Kou J
J Biopharm Stat; 2004 May; 14(2):275-90. PubMed ID: 15206526
[TBL] [Abstract][Full Text] [Related]
5. Statistical considerations for noninferiority/equivalence trials in vaccine development.
Wang WW; Mehrotra DV; Chan IS; Heyse JF
J Biopharm Stat; 2006; 16(4):429-41. PubMed ID: 16892905
[TBL] [Abstract][Full Text] [Related]
6. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
Lui KJ; Chang KC
Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
[TBL] [Abstract][Full Text] [Related]
7. The determination of equivalent doses of standardized allergen vaccines.
Slater JE; Pastor RW
J Allergy Clin Immunol; 2000 Mar; 105(3):468-74. PubMed ID: 10719295
[TBL] [Abstract][Full Text] [Related]
8. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 3: Pig islet product manufacturing and release testing.
Korbutt GS
Xenotransplantation; 2009; 16(4):223-8. PubMed ID: 19799762
[TBL] [Abstract][Full Text] [Related]
9. Tracking vaccine lot lifecycles using reports to the vaccine adverse event reporting system (VAERS).
Dayan GH; Iskander J; Glasser J; English-Bullard R; Fullerton KE; Chen R
Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):671-6. PubMed ID: 15662715
[TBL] [Abstract][Full Text] [Related]
10. A simple formula for sample size calculation in equivalence studies.
Zhang P
J Biopharm Stat; 2003 Aug; 13(3):529-38. PubMed ID: 12921399
[TBL] [Abstract][Full Text] [Related]
11. Consistency testing of diphtheria and tetanus to replace potency testing for lot release.
Kreeftenberg JG
Dev Biol (Basel); 2002; 111():291-8. PubMed ID: 12678252
[TBL] [Abstract][Full Text] [Related]
12. Minimization of sample size when comparing two small probabilities in a non-inferiority safety trial.
de Boo TM; Zielhuis GA
Stat Med; 2004 Jun; 23(11):1683-99. PubMed ID: 15160402
[TBL] [Abstract][Full Text] [Related]
13. [Methodological and statistical aspects of equivalence and non inferiority trials].
Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P
Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296
[TBL] [Abstract][Full Text] [Related]
14. On testing equivalence of three populations.
Wiens BL; Iglewicz B
J Biopharm Stat; 1999 Aug; 9(3):465-83. PubMed ID: 10473032
[TBL] [Abstract][Full Text] [Related]
15. Size isn't everything.
Hampton JR
Stat Med; 2002 Oct; 21(19):2807-14. PubMed ID: 12325096
[TBL] [Abstract][Full Text] [Related]
16. A practical approach for comparing means of two groups without equal variance assumption.
Wang H; Chow SC
Stat Med; 2002 Oct; 21(20):3137-51. PubMed ID: 12369087
[TBL] [Abstract][Full Text] [Related]
17. Group sequential design and analysis of clinical equivalence assessment for generic nonsystematic drug products.
Tsong Y; Zhang JJ; Wang SJ
J Biopharm Stat; 2004 May; 14(2):359-73. PubMed ID: 15206533
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic equivalence: fallacies and falsification.
Garrett AD
Stat Med; 2003 Mar; 22(5):741-62. PubMed ID: 12587103
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of vaccine stability through annual stability and comparability studies.
Schofield TL
Biologicals; 2009 Nov; 37(6):397-402; discussion 421-3. PubMed ID: 19717311
[TBL] [Abstract][Full Text] [Related]
20. Lessons from preventive infectious disease vaccines.
Chandler DK; Midthun K; Goldenthal KL
Dev Biol (Basel); 2004; 116():61-6; discussion 69-76. PubMed ID: 15603184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
